Latest Deep Track Capital, LP Stock Portfolio
$6.87Billion | No. of Holdings #66
Deep Track Capital, LP Performance
2026 Q2+22.57%
YTD+18.91%
2025+52.17%
About Deep Track Capital, LP and 13F Hedge Fund Stock Holdings
On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Deep Track Capital, LP reported an equity portfolio of $6.9 Billions as of 30 Jun, 2026. <br><br> The top stock holdings of Deep Track Capital, LP are GH, IMVT, . The fund has invested 7.4% of it's portfolio in GUARDANT HEALTH INC and 5.2% of portfolio in IMMUNOVANT INC. <br><br> The fund managers got completely rid off APELLIS PHARMACEUTICALS INC (APLS), CENTESSA PHARMACEUTICALS PLC (CNTA) and BRIDGEBIO PHARMA INC (BBIO) stocks. They significantly reduced their stock positions in IMMUNOCORE HLDGS PLC (IMCR), CYTOKINETICS INC (CYTK) and MBX BIOSCIENCES INC. Deep Track Capital, LP opened new stock positions in ALNYLAM PHARMACEUTICALS INC (ALNY), HEMAB THERAPEUTICS HLDGS INC and GH RESEARCH PLC (GHRS). The fund showed a lot of confidence in some stocks as they added substantially to VERADERMICS INC, BIOMARIN PHARMACEUTICAL INC (BMRN) and VIRIDIAN THERAPEUTICS INC (VRDN).
Deep Track Capital, LP Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$6.87Billion
as of Aug 14, 2026Deep Track Capital, LP Annual Return Estimates Vs S&P 500
Our best estimate is that Deep Track Capital, LP made a return of 22.57% in the last quarter. In trailing 12 months, it's portfolio return was 95.33%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| alnylam pharmaceuticals inc | 248,350,000 |
| hemab therapeutics hldgs inc | 132,305,000 |
| gh research plc | 89,600,000 |
| united therapeutics corp del | 66,978,900 |
| avalo therapeutics inc | 66,712,800 |
| altimmune inc | 58,520,000 |
| genedx holdings corp | 48,055,000 |
| harrow inc | 41,153,400 |
New stocks bought by Deep Track Capital, LP
Additions
| Ticker | % Inc. |
|---|---|
| veradermics inc | 300 |
| biomarin pharmaceutical inc | 187 |
| viridian therapeutics inc | 157 |
| celldex therapeutics inc new | 128 |
| cogent biosciences inc | 100 |
| genmab a/s | 54.23 |
| tango therapeutics inc | 52.73 |
| personalis inc | 33.33 |
Additions to existing portfolio by Deep Track Capital, LP
Reductions
| Ticker | % Reduced |
|---|---|
| immunocore hldgs plc | -83.89 |
| cytokinetics inc | -49.07 |
| mbx biosciences inc | -37.17 |
| axsome therapeutics inc. | -36.36 |
| inventiva sa | -34.56 |
| enanta pharmaceuticals inc | -26.2 |
| kura oncology inc | -25.15 |
| dyne therapeutics inc | -25.00 |
Deep Track Capital, LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| geron corp | -47,263,200 |
| apellis pharmaceuticals inc | -182,337,000 |
| engene holdings inc | -29,811,300 |
| centessa pharmaceuticals plc | -125,437,000 |
| larimar therapeutics inc | -6,750,000 |
| cybin inc | -6,303,060 |
| janux therapeutics inc | -16,503,300 |
| soleno therapeutics inc | -36,115,200 |
Deep Track Capital, LP got rid off the above stocks
Sector Distribution
Deep Track Capital, LP has about 68.6% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 68.6 |
| Others | 30.7 |
Market Cap. Distribution
Deep Track Capital, LP has about 17.5% of it's portfolio invested in the large-cap and mega-cap stocks.
- MID-CAP
- UNALLOCATED
- LARGE-CAP
- SMALL-CAP
| Category | % |
|---|---|
| MID-CAP | 34.4 |
| UNALLOCATED | 30.7 |
| LARGE-CAP | 17.5 |
| SMALL-CAP | 17.2 |
Stocks belong to which Index?
About 49.5% of the stocks held by Deep Track Capital, LP either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| Others | 50.5 |
| RUSSELL 2000 | 49.5 |
| Top 5 Winners (%) | % | |
|---|---|---|
| CMPS | compass pathways plc | 155.9 % |
definium therapeutics inc | 142.7 % | |
oruka therapeutics inc | 91.5 % | |
| PSNL | personalis inc | 84.9 % |
mbx biosciences inc | 69.1 % | |
Deep Track Capital, LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Deep Track Capital, LP
Deep Track Capital, LP has 66 stocks in it's portfolio. About 39.6% of the portfolio is in top 10 stocks. TARS proved to be the most loss making stock for the portfolio. GH was the most profitable stock for Deep Track Capital, LP last quarter.
$6.79BTotal Value
80.00Positions
14 Aug, 2026Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 Aclaris Therapeutics Inc Deep Track Capital, LP's holding in Aclaris Therapeutics Inc over time | 0.72% | 9,345,000 | $49.44M 0.72% | 0%unchanged 0 percentunchanged | |
 Aligos Therapeutics Inc Deep Track Capital, LP's holding in Aligos Therapeutics Inc over time | 0.04% | 444,110 | $2.56M 0.04% | 0%unchanged 0 percentunchanged | |
 Alkermes Plc Alkermes PlcALKS Deep Track Capital, LP's holding in Alkermes Plc over time | 3.05% | 4,000,000 | $209.58M 3.05% | 11.41%increased 11.41 percentadded | |
 Alnylam Pharmaceuticals Inc Deep Track Capital, LP's holding in Alnylam Pharmaceuticals Inc over time | 3.62% | 825,000 | $248.35M 3.62% | Newnew position | |
 Altimmune Inc Deep Track Capital, LP's holding in Altimmune Inc over time | 0.85% | 19,250,000 | $58.52M 0.85% | Newnew position | |
 Ani Pharmaceuticals Inc Deep Track Capital, LP's holding in Ani Pharmaceuticals Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Apellis Pharmaceuticals Inc Deep Track Capital, LP's holding in Apellis Pharmaceuticals Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Avalo Therapeutics Inc Deep Track Capital, LP's holding in Avalo Therapeutics Inc over time | 0.97% | 3,610,000 | $66.71M 0.97% | Newnew position | |
 Axsome Therapeutics Inc. Deep Track Capital, LP's holding in Axsome Therapeutics Inc. over time | 2.49% | 700,000 | $171.34M 2.49% | 36.36%decreased 36.36 percentreduced | |
 Bridgebio Pharma Inc Bridgebio Pharma Inc BBIO Deep Track Capital, LP's holding in Bridgebio Pharma Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Beam Therapeutics Inc Deep Track Capital, LP's holding in Beam Therapeutics Inc over time | 0.5% | 1,000,000 | $34.32M 0.5% | 21.84%increased 21.84 percentadded | |
 Biomarin Pharmaceutical Inc Deep Track Capital, LP's holding in Biomarin Pharmaceutical Inc over time | 2.76% | 3,307,480 | $189.25M 2.76% | 187.61%increased 187.61 percentadded | |
 Celldex Therapeutics Inc New Deep Track Capital, LP's holding in Celldex Therapeutics Inc New over time | 1.59% | 2,939,150 | $109.37M 1.59% | 128.91%increased 128.91 percentadded | |
 CMPS Compass Pathways PlcCompass Pathways PlcCMPS | 2.5% | 12,161,500 | $172.09M 2.5% | 0%unchanged 0 percentunchanged | |
 Centessa Pharmaceuticals Plc Deep Track Capital, LP's holding in Centessa Pharmaceuticals Plc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Context Therapeutics Inc Deep Track Capital, LP's holding in Context Therapeutics Inc over time | 0.06% | 7,419,360 | $4.11M 0.06% | 0%unchanged 0 percentunchanged | |
 Cogent Biosciences Inc Deep Track Capital, LP's holding in Cogent Biosciences Inc over time | 1.13% | 2,000,000 | $77.40M 1.13% | 100%increased 100 percentadded | |
 Cormedix Inc Cormedix IncCRMD Deep Track Capital, LP's holding in Cormedix Inc over time | 0.72% | 6,274,080 | $49.25M 0.72% | 0%unchanged 0 percentunchanged | |
 Corvus Pharmaceuticals Inc Deep Track Capital, LP's holding in Corvus Pharmaceuticals Inc over time | 0.54% | 2,491,940 | $37.23M 0.54% | 0.02%increased 0.02 percentadded | |
 CYBN Cybin Inc Cybin IncCYBN | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |